LITTLE Mix star Jesy Nelson has revealed that her baby twins have been diagnosed with a severe form of Spinal Muscular Atrophy. In a heart-breaking Instagram post, the singer said her daughters could ...

Jesy Nelson has shared the devastating news her twin girls have been diagnosed with a life-changing and rare genetic condition which means they may never walk. The 34-year-old former Little mix star ...

SMA type 3 is a hereditary disease that affects motor neurons. People may also refer to it as Kugelberg-Welander disease. Symptoms usually begin after 18 months of age. Children with SMA type 3 can ...

"Our study demonstrated that profound impairments in swallowing are extremely common within the first year of life. This of course has tremendous clinical relevance as it highlights the importance of ...

Jesy Nelson has bravely shared a devastating diagnosis for her twin babies - that they will never walk. The Little Mix star revealed her baby twins have been diagnosed with the incurable genetic ...

Medical researchers have uncovered a novel mechanism that leads to motor neuron degeneration in spinal muscular atrophy (SMA). This discovery offers a new target for treatment that overcomes important ...

Days after the Little Mix alum shared her and fiancé Zion Foster’s twin daughters, 7-month-old Ocean Jade and Story Monroe, were diagnosed with Spinal Muscular Atrophy Type 1 (SMA)—a genetic disorder ...

The tiny zebrafish is helping researchers rapidly determine whether a newborn's genetic mutation is likely to cause spinal ...

Spinal muscular atrophy (SMA) is a debilitating genetic condition that’s usually fatal by a few years of age. But an intriguing case study might demonstrate a simple new treatment, with a child ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

"The benefits of newborn screening identified in the study presented here encompass not only the achievement of motor milestones, but also a reduced need for ventilator support or tube feeding and a ...

This is an open-label study of daily oral risdiplam in infants aged 1 to 42 days with genetically diagnosed SMA. HealthDay News — Infants up to 6 weeks of age with genetically diagnosed spinal ...